Related Experiment Videos
A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells
1Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, Arizona 85724-5024, USA.
Abstract:
Cancer cell lines transfected with thioredoxin show increased anchorage-independent growth and decreased sensitivity to induction of apoptosis by a number of anticancer drugs. The present studies were undertaken to evaluate further the role of thioredoxin in cell growth and drug-induced apoptosis. A redox-inactive mutant thioredoxin was stably transfected into WEHI7.2 mouse lymphocytic leukemia cells and two clones were examined for growth characteristics and the induction of apoptosis by dexamethasone, etoposide, doxorubicin, and staurosporine. These clones each exhibited a 71% increase in doubling time in solution and a 20 and 75% reduction in colony formation in soft agarose. The transfected cells also showed increased susceptibility to apoptosis induced by dexamethasone, etoposide, doxorubicin, and staurosporine compared with controls. The results of this study suggest that thioredoxin can regulate the growth rate of cells and that thioredoxin is a critical component in the pathway leading to drug-induced apoptosis in WEHI7.2 cells.
Insights
Thioredoxin influences cancer cell growth and apoptosis. This study found that a redox-inactive mutant thioredoxin increased cell doubling time and reduced colony formation, while increasing susceptibility to drug-induced apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Thioredoxin (TXN) is a key redox-regulating protein.
- TXN overexpression is implicated in cancer progression and drug resistance.
- Its precise role in cell growth and apoptosis requires further elucidation.
Purpose of the Study:
- To investigate the role of thioredoxin in regulating cell growth.
- To determine thioredoxin's involvement in drug-induced apoptosis.
- To utilize a redox-inactive mutant to probe TXN function.
Main Methods:
- Stable transfection of WEHI7.2 mouse lymphocytic leukemia cells with a redox-inactive thioredoxin mutant.
- Assessment of cell growth characteristics, including doubling time and anchorage-independent growth.
- Evaluation of apoptosis induction by anticancer drugs (dexamethasone, etoposide, doxorubicin, staurosporine).
Main Results:
- Transfected clones exhibited a 71% increase in doubling time.
- Colony formation in soft agarose was reduced by 20% and 75%.
- Transfected cells showed increased susceptibility to drug-induced apoptosis.
Conclusions:
- Thioredoxin regulates cancer cell growth rate.
- Thioredoxin is a critical component in the pathway of drug-induced apoptosis.
- Modulating thioredoxin activity may offer therapeutic strategies for cancer treatment.